BioLife Solutions, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.89 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $1.90.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2018-03-31 was $1.16.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was -$1.00.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2012 was $0.00.
- BioLife Solutions, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2011 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.89 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $1.90 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | $1.83 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $1.83 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $2.33 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $2.50 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2018-03-31 | $1.16 10-Q · filed 2018-05-11 | |||
| 2014-06-30 | $1.22 10-Q · filed 2014-08-07 | |||
| 2013-12-31 | -$1.00 10-K · filed 2014-02-12 | |||
| 2013-09-30 | $0.07 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | -$0.08 10-Q · filed 2013-08-12 | |||
| 2013-03-31 | -$0.08 10-Q · filed 2013-05-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-02-12 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |